| PID_in_paper | age(yr) | gender | race/ethnicity | infection_duration | pre_ART_duration | ART | ART_duration | pre_suppression_duration | suppression_duration | proviral_DNA_copies_at_sampling | viral_RNA_copies_at_sampling | suppression_status | CD4_at_sampling | sample_comment |
|---|
| 22 | 44(yr) | | | | | ABC/3TC, DTG | 117.6(month) | | | | | supressed | 687(cells/ul) | chronic progressor, data from timepoint 2 |
| 746 | 48(yr) | | | | | TDF/FTC, EGV/c | 123(month) | | | | | supressed | 667(cells/ul) | chronic progressor, data from timepoint 2 |
| 1211 | 49(yr) | | | | | ABC/3TC, ATV/r | 63.3(month) | | | | | supressed | 517(cells/ul) | chronic progressor, data from timepoint 2 |
| 548 | 51(yr) | | | | | TDF/FTC, EFV | 140.2(month) | | | | | supressed | 727(cells/ul) | chronic progressor, data from timepoint 2 |
| 1194 | 63(yr) | | | | | ABC/3TC, DTG | 88.8(month) | | | | | supressed | 329(cells/ul) | conroller, date from timepoint 2 |
| 1532 | 54(yr) | | | | | TDF/FTC,RAL | 45.6(month) | | | | | supressed | 369(cells/ul) | conroller, date from timepoint 2 |
| 583 | 48(yr) | | | | | TDF/FTC, EFV | 132.8(month) | | | | | supressed | 894(cells/ul) | chronic progressor, data from timepoint 2 |
| 1124 | 62(yr) | | | | | TAF/FTC, DTG | 85.1(month) | | | | | supressed | 353(cells/ul) | conroller, date from timepoint 2 |
